ProShare Advisors’s St Jude Medical STJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-30,898
Closed -$2.48M 1742
2016
Q4
$2.48M Buy
30,898
+6,167
+25% +$489K 0.03% 487
2016
Q3
$1.97M Sell
24,731
-11,533
-32% -$931K 0.03% 498
2016
Q2
$2.83M Sell
36,264
-15,322
-30% -$1.09M 0.04% 373
2016
Q1
$2.84M Sell
51,586
-16,760
-25% -$913K 0.04% 357
2015
Q4
$4.22M Buy
68,346
+1,745
+3% +$110K 0.05% 321
2015
Q3
$4.2M Buy
66,601
+21,867
+49% +$1.56M 0.06% 304
2015
Q2
$3.27M Sell
44,734
-7,899
-15% -$571K 0.05% 367
2015
Q1
$3.44M Sell
52,633
-6,002
-10% -$399K 0.04% 400
2014
Q4
$3.81M Buy
58,635
+9,099
+18% +$586K 0.04% 384
2014
Q3
$2.98M Sell
49,536
-4,683
-9% -$306K 0.04% 503
2014
Q2
$3.75M Sell
54,219
-4,516
-8% -$293K 0.05% 393
2014
Q1
$3.84M Buy
58,735
+2,945
+5% +$192K 0.05% 366
2013
Q4
$3.46M Buy
55,790
+27,719
+99% +$1.61M 0.05% 454
2013
Q3
$1.51M Sell
28,071
-18,683
-40% -$962K 0.04% 571
2013
Q2
$2.13M Buy
+46,754
New +$2.03M 0.04% 433

Other funds holding STJ

ProShare Advisors's STJ Position: Q1 2017 in Review

ProShare Advisors sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 30,898 shares — an estimated $2.48M sold.

ProShare Advisors first reported a position in STJ in Q2 2013 and held it in 15 quarters. The position peaked at $4.22M in Q4 2015. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • ProShare Advisors reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • ProShare Advisors sold 30,898 St Jude Medical shares in Q1 2017, an estimated $2.48M.
  • ProShare Advisors first reported a position in St Jude Medical in Q2 2013 and held it in 15 quarters.
  • ProShare Advisors's St Jude Medical position peaked at $4.22M in Q4 2015.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on ProShare Advisors's 13F filing for Q1 2017, filed 25 Apr 2017.